de Bie Mihály K, Ajmone Marsan Nina, Gaasbeek André, Bax Jeroen J, Groeneveld Marc, Gabreels Bas A, Delgado Victoria, Rabelink Ton J, Schalij Martin J, Jukema J Wouter
Department of Cardiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Int J Nephrol. 2012;2012:963504. doi: 10.1155/2012/963504. Epub 2012 May 9.
Background. Diastolic dysfunction is common among dialysis patients and is associated with increased morbidity and mortality. Novel echocardiographic speckle tracking strain analysis permits accurate assessment of left ventricular diastolic function, independent of loading conditions and taking all myocardial segments into account. The aim of the study was to evaluate the prevalence of diastolic dysfunction in chronic dialysis patients using this novel technique, and to identify its determinants among clinical and echocardiographic variables. Methods. Patients currently enrolled in the ICD2 study protocol were included for this analysis. Next to conventional echo measurements diastolic function was also assessed by global diastolic strain rate during isovolumic relaxation (SRIVR). Results. A total of 77 patients were included (age 67 ± 8 years, 74% male). When defined as E/SRIVR ≥236, the prevalence of diastolic dysfunction was higher compared to more conventional measurements (48% versus 39%). Left ventricular mass (OR 1.02, 95% CI 1.00-1.04, P = 0.014) and pulse wave velocity (OR 1.34, 95% CI 1.07-1.68, P = 0.01) were independent determinants of diastolic dysfunction. Conclusion. Diastolic dysfunction is highly prevalent among dialysis patients and might be underestimated using conventional measurements. Left ventricular mass and pulse wave velocity were the only determinants of diastolic dysfunction in these patients.
背景。舒张功能障碍在透析患者中很常见,且与发病率和死亡率增加相关。新型超声心动图斑点追踪应变分析能够独立于负荷条件并考虑所有心肌节段,准确评估左心室舒张功能。本研究的目的是使用这种新技术评估慢性透析患者舒张功能障碍的患病率,并在临床和超声心动图变量中确定其决定因素。方法。纳入目前参与ICD2研究方案的患者进行此次分析。除了传统的超声心动图测量外,还通过等容舒张期的整体舒张应变率(SRIVR)评估舒张功能。结果。共纳入77例患者(年龄67±8岁,74%为男性)。当定义为E/SRIVR≥236时,舒张功能障碍的患病率高于更传统的测量方法(48%对39%)。左心室质量(OR 1.02,95%CI 1.00 - 1.04,P = 0.014)和脉搏波速度(OR 1.34,95%CI 1.07 - 1.68,P = 0.01)是舒张功能障碍的独立决定因素。结论。舒张功能障碍在透析患者中非常普遍,使用传统测量方法可能会低估其患病率。左心室质量和脉搏波速度是这些患者舒张功能障碍的唯一决定因素。